These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1930610)

  • 1. Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors.
    Wong DT; Threlkeld PG; Robertson DW
    Neuropsychopharmacology; 1991 Aug; 5(1):43-7. PubMed ID: 1930610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1988 Oct; 247(1):169-73. PubMed ID: 3139864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
    Pranzatelli MR; Murthy JN; Pluchino RS
    J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
    Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine-induced inhibition of synaptosomal [3H]5-HT release: possible Ca(2+)-channel inhibition.
    Stauderman KA; Gandhi VC; Jones DJ
    Life Sci; 1992; 50(26):2125-38. PubMed ID: 1608295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J; Hyttel J; Overø KF
    Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake.
    Sugrue MF
    Br J Pharmacol; 1984 Apr; 81(4):651-7. PubMed ID: 6722394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
    Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM
    Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
    Klimek V; Zak-Knapik J; Mackowiak M
    J Psychiatry Neurosci; 1994 Jan; 19(1):63-7. PubMed ID: 8148368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635.
    Hervás I; Vilaró MT; Romero L; Scorza MC; Mengod G; Artigas F
    Neuropsychopharmacology; 2001 Jan; 24(1):11-20. PubMed ID: 11106871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antidepressant effects of 5-HT uptake inhibitors.
    Aberg-Wistedt A
    Br J Psychiatry Suppl; 1989 Dec; (8):32-40. PubMed ID: 2692638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin-1C sites in the choroid plexus are not linked in a stimulatory or inhibitory way to adenylate cyclase.
    Palacios JM; Markstein R; Pazos A
    Brain Res; 1986 Aug; 380(1):151-4. PubMed ID: 3019464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.
    Pälvimäki EP; Roth BL; Majasuo H; Laakso A; Kuoppamäki M; Syvälahti E; Hietala J
    Psychopharmacology (Berl); 1996 Aug; 126(3):234-40. PubMed ID: 8876023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between serotonin uptake inhibitors and alpha-2 adrenergic heteroreceptors in the rat hypothalamus.
    Blier P; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1990 Jul; 254(1):236-44. PubMed ID: 2164092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus.
    Laakso A; Pälvimäki EP; Kuoppamäki M; Syvälahti E; Hietala J
    Neuropsychopharmacology; 1996 Aug; 15(2):143-51. PubMed ID: 8840350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The existence on the serotonin carrier of 2 independent sites for the specific binding of trazodone and imizin].
    Katanasov AB; Brusov OS
    Farmakol Toksikol; 1988; 51(6):32-5. PubMed ID: 2976683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization.
    Hoyer D; Waeber C; Schoeffter P; Palacios JM; Dravid A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Mar; 339(3):252-8. PubMed ID: 2725702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer.
    Hyttel J; Bøgesø KP; Perregaard J; Sánchez C
    J Neural Transm Gen Sect; 1992; 88(2):157-60. PubMed ID: 1632943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.